Glimepiride Tablet
Product Images NDC 43063-122

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 43063-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063122 Label (43063122)

Glimepiride USP 4 mg oral tablets label from PD-Rx Pharmaceuticals, Inc. The label indicates a package containing 90 tablets with an NDC of 43063-122-90. It includes warnings about keeping out of reach of children, dosage and storage instructions, lot number C23A60, and expiration date 08/2025. The label also features a QR code and the manufacturer's location in Oklahoma City, OK.*

FDA Label Image

Structure (Structure)

Chemical structure of Glimepiride, showing the molecular arrangement of its atoms and bonds as part of the product's active ingredient representation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.